GlassScriptPhysician profile
Austin Chinn
NPI 1225599236
$5,893.15
in general payments reported to CMS, 2019-2025
12 companies · $1,126 in 2025
The $1,126 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,350 · 2022: $2,278 · 2023: $914 · 2024: $225 · 2025: $1,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238 · Travel and Lodging: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.47 |
| Travel and Lodging | $1,026.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,372.93 | 2022-2025 | Infinity, Ortholoc 3di, T2 |
| Medwest Associates | $1,200.00 | 2021 | |
| Kerecis Limited | $785.91 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $411.41 | 2022 | |
| Medical Device Business Services, INC. | $405.96 | 2023 | |
| Depuy Synthes Sales INC. | $392.60 | 2023-2025 | Hammerlock, Motoband, Dynaforce |
| Horizon Therapeutics Plc | $149.99 | 2021 | |
| Ferring Pharmaceuticals INC. | $53.74 | 2024-2025 | Euflexxa |
| Smith+Nephew, INC. | $37.56 | 2022-2023 | Grafix, Stravix Pl |
| Sanofi-Aventis U.S. LLC | $35.71 | 2023 | |
| Oak Med, INC. | $33.11 | 2024-2025 | |
| Orthofix Medical, INC. | $14.23 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Chinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.